Gene mutations in Mycobacterium tuberculosis: Multidrug-resistant TB as an emerging global public health crisis

Tuberculosis

Volumn 95, Issue 1, 2015, Pages 1-5

  Mishra, Rahul ^a   Shukla, Priyanka ^a   Huang, Wei ^a   Hu, Ning ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Drug resistance; Gene mutation; MDR TB; MTB; XDR TB

Indexed keywords

EPIDEMIC; GENE MUTATION; HETERODUPLEX ANALYSIS; HUMAN; HYBRIDIZATION; MOLECULAR BEACON; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; REVIEW; RISK FACTOR; SHORT COURSE THERAPY; SINGLE STRAND CONFORMATION POLYMORPHISM; COMMUNICABLE DISEASES, EMERGING; DIRECTLY OBSERVED THERAPY; FORECASTING; GENETICS; HEALTH; MICROBIOLOGICAL EXAMINATION; MOLECULAR DIAGNOSIS; MUTATION; PROCEDURES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

TUBERCULOSTATIC AGENT;

ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNIQUES; COMMUNICABLE DISEASES, EMERGING; DIRECTLY OBSERVED THERAPY; FORECASTING; GLOBAL HEALTH; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84920605368     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2014.08.012     Document Type: Review

References (43)

1. WHO Global tuberculosis control 2008, surveillance, planning, financing 2008 WHO RegionalOffice For the Western Pacific
2. R. Johnson, E.M. Streicher, G.E. Louw, and R.M. Warren Drug resistance in M. tuberculosis Curr Issues Mol Biol 8 2008 97 112
3. A. Sajduda, A. Brzostek, M. Popławska, E. Augustynowicz-Kopec, Z. Zwolska, S. Niemann, J. Dziadek, and D. Hillemann Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland J Clin Microbiol 42 6 2004 2425 2431
4. World Health Organization WHO report 2002. Global tuberculosis control. Surveillance, planning, financing 2002 World Health Organization Geneva, Switzerland
5. A. Pablos-Mendez, M.C. Raviglione, A. Laszlo, N. Binkin, H.L. Rieder, F. Bustreo, D.L. Cohn, C.S. Lambregts-van Weezenbeek, S.J. Kim, P. Chaulet, and P. Nunn Global surveillance for antituberculosis-drug resistance, 1994-1997 N Engl J Med 338 1998 1641 1649
6. W.R. McClure, and C.L. Cech On the mechanism of rifampicin inhibition of RNA synthesis J Biol Chem 253 1978 8949 8956
7. S. Spindola de Miranda, A. Kritski, I. Filliol, C. Mabilat, G. Panteix, and E. Drouet Mutations in the rpoBgene of rifampicin-resistant Mycobacterium tuberculosis strains isolated in Brazil and France Mem Inst Oswaldo Cruz 96 2001 247 250
8. A. Telenti, P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M.J. Colston, L. Matter, K. Schopfer, and T. Bodmer Detection of rifampicin-resistance mutations in mycobacterium tuberculosis Lancet 341 1993 647 650
9. T. Kocagoz, Z. Saribas, and A. Alp Rapid determination of rifampin resistance in clinical isolates of Mycobacterium tuberculosis by real-time PCR J Clin Microbiol 43 2005 6015 6019
10. H. Huang, Q. Jin, Y. Ma, X. Chen, and Y. Zhuang Characterization of rpoBmutations in rifampicin-resistant mycobacterium tuberculosis isolated in China Tuberc Edinb 82 2002 79 83
11. C. Mani, N. Selvakumar, S. Narayanan, and P.R. Narayanan Mutations in the rpoBgene of multidrug-resistant mycobacterium tuberculosis clinical isolates from India J Clin Microbiol 39 2001 2987 2990
12. X. Tang, S.L. Morris, J.J. Langone, and L.E. Bockstahler Microarray and allele specific PCR detection of point mutations in mycobacterium tuberculosis genes associated with drug resistance J Microbiol Methods 63 2005 318 330
13. S.W. Dooley, and P.M. Simone The extent and management of drug-resistant tuberculosis: the American experience. Clinical tuberculosis 1994 Chapman & Hall London 171 189
14. T.R. Sterling, H.P. Lehmann, and T.R. Frieden Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis Br Med J 326 2003 574
15. I. Bastian, R. Stapledon, and R. Colebunders Current thinking on the management of tuberculosis Curr Opin Pulm Med 9 2003 186 192
16. H.M. Blumberg, W.J. Burman, R.E. Chaisson, C.L. Daley, S.C. Etkind, L.N. Friedman, P. Fujiwara, M. Grzemska, P.C. Hopewell, M.D. Iseman, R.M. Jasmer, V. Koppaka, R.I. Menzies, R.J. O'Brien, R.R. Reves, L.B. Reichman, P.M. Simone, J.R. Starke, and A.A. Vernon American Thoracic Society/Centers for disease control and Prevention/Infectious diseases Society of America: treatment of tuberculosis Am J Respir Crit Care Med 167 2003 603 662
17. I. Bastian, L. Rigouts, A. Van Deun, and F. Portaels Directly observed treatment, short-course strategy and multidrug-resistant tuberculosis: are any modifications required? Bull World Health Organ 78 2000 238 251
18. C. Lienhardt, and J.A. Ogden Tuberculosis control in resource-poor countries: have we reached the limits of the universal paradigm? Trop Med Int Health 9 2004 833 841
19. World Health Organization WHO report 2003: global tuberculosis control 2003
20. T.C. Victor, P.D. van Helden, and R. Warren Prediction of drug resistance in M. tuberculosis: molecular mechanisms, tools, and applications IUBMB Life 53 2002 231 237
21. T.C. Victor, A.M. Jordaan, A. van Rie, G.D. van der Spuy, M. Richardson, P.D. van Helden, and R. Warren Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy Tuber Lung Dis 79 1999 343 348
22. I. Mokrousov, N.V. Bhanu, P.N. Suffys, G.V. Kadival, S.F. Yap, S.N. Cho, A.M. Jordaan, O. Narvskaya, U.B. Singh, H.M. Gomes, H. Lee, S.P. Kulkarni, K.C. Lim, B.K. Khan, D. van Soolingen, T.C. Victor, and L.M. Schouls Multicenter evaluation of reverse line blot assay for detection of drug resistance in mycobacterium tuberculosis clinical isolates J Microbiol Methods 57 2004 323 335
23. B.J. Kim, K.H. Lee, Y.J. Yun, E.M. Park, Y.G. Park, G.H. Bai, C.Y. Cha, and Y.H. Kook Simultaneous identification of rifampin-resistant mycobacterium tuberculosis and nontuberculous mycobacteria by polymerase chain reaction-single strand conformation polymorphism and sequence analysis of the RNA polymerase gene (rpoB) J Microbiol Methods 58 2004 111 118
24. R.F. Cardoso, R.C. Cooksey, G.P. Morlock, P. Barco, L. Cecon, F. Forestiero, C.Q. Leite, D.N. Sato, M.L. ShikamaMd, E.M. Mamizuka, R.D. Hirata, and M.H. Hirata Screening and characterization of mutations in isoniazid-resistant mycobacterium tuberculosis isolates obtained in Brazil Antimicrob Agents Chemother 48 2004 3373 3381
25. Z. Fang, C. Doig, A. Rayner, D.T. Kenna, B. Watt, and K.J. Forbes Molecular evidence for heterogeneity of the multiple-drug-resistant mycobacterium tuberculosis population in Scotland (1990 to 1997) J Clin Microbiol 37 1999 998 1003
26. B. Heym, P.M. Alzari, N. Honore, and S.T. Cole Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in mycobacterium tuberculosis Mol Microbiol 15 1995 235 245
27. G.S. Pretorius, P.D. van Helden, F. Sirgel, K.D. Eisenach, and T.C. Victor Mutations in katG gene sequences in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis are rare Antimicrob Agents Chemother 39 1995 2276 2281
28. H.H. El Hajj, S.A. Marras, S. Tyagi, F.R. Kramer, and D. Alland Detection of rifampin resistance in mycobacterium tuberculosis in a single tube with molecular beacons J Clin Microbiol 39 2001 4131 4137
29. A.S. Piatek, A. Telenti, M.R. Murray, H. el Hajj, W.R. Jacobs Jr., F.R. Kramer, and D. Alland Genotypic analysis of mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing Antimicrob Agents Chemother 44 2000 103 110
30. A.S. Piatek, S. Tyagi, A.C. Pol, A. Telenti, L.P. Miller, F.R. MKramer, and D. Alland Molecular beacon sequence analysis for detecting drug resistance in mycobacterium tuberculosis Nat Biotechnol 16 1998 359 363
31. C.R. Newton, A. Graham, L.E. Heptinstall, S.J. Powell, C. Summers, N. Kalsheker, J.C. Smith, and A.F. Markham Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS) Nucleic Acids Res 17 1989 2503 2516
32. D.E. Snider Jr., R.C. Good, J.O. Kilburn, L.F. Laskowski Jr., R.H. Lusk, J.J. Marr, Z. Reggiardo, and G. Middlebrook Rapid drug-susceptibility testing of mycobacterium tuberculosis Am Rev Respir Dis 123 1981 402 406
33. J.J. Tarrand, and D.H. Groschel Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of mycobacterium tuberculosis J Clin Microbiol 21 1985 941 946
34. A. van Rie, R.M. Warren, N. Beyers, R.P. Gie, C.N. Classen, M. Richardson, S.L. Sampson, T.C. Victor, and P.D. van Helden Transmission of a multidrug-resistant mycobacterium tuberculosis strain resembling "strain W" among noninstitutionalized, human immunodeficiency virus-seronegative patients J Infect Dis 180 1999 1608 1615
35. M.A. Fischl, R.B. Uttamchandani, G.L. Daikos, R.B. Poblete, J.N. Moreno, R.R. Reyes, A.M. Boota, L.M. Thompson, T.J. Cleary, and S. Lai An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection Ann Intern Med 117 1992 177 183
36. B.R. Edlin, J.I. Tokars, M.H. Grieco, J.T. Crawford, J. Williams, E.M. Sordillo, K.R. Ong, J.O. Kilburn, S.W. Dooley, and K.G. Castro An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome N Engl J Med 326 1992 1514 1521
37. P.J. Bifani, B.B. Plikaytis, V. Kapur, K. Stockbauer, X. Pan, M.L. Lutfey, S.L. Moghazeh, W. Eisner, T.M. Daniel, M.H. Kaplan, J.T. Crawford, J.M. Musser, and B.N. Kreiswirth Origin and interstate spread of a New York city multidrug-resistant mycobacterium tuberculosis clone family JAMA 275 1996 452 457
38. R.C. Cooksey, G.P. Morlock, A. McQueen, S.E. Glickman, and J.T. Crawford Characterization of streptomycin resistance mechanisms among mycobacterium tuberculosis isolates from patients in New York City Antimicrob Agents Chemother 40 1996 1186 1188
39. C. Beck-Sague, S.W. Dooley, M.D. Hutton, J. Otten, A. Breeden, J.T. Crawford, A.E. Pitchenik, C. Woodley, G. Cauthen, and W.R. Jarvis Hospital outbreak of multidrug-resistant mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients JAMA 268 1992 1280 1286
40. M.L. Pearson, J.A. Jereb, T.R. Frieden, J.T. Crawford, B.J. Davis, S.W. Dooley, and W.R. Jarvis Nosocomial transmission of multidrug-resistant mycobacterium tuberculosis. A risk to patients and health care workers Ann Intern Med 117 1992 191 196
41. J.A. Jereb, R.M. Klevens, T.D. Privett, P.J. Smith, J.T. Crawford, V.L. Sharp, B.J. Davis, W.R. Jarvis, and S.W. Dooley Tuberculosis in health care workers at a hospital with an outbreak of multi drug resistant mycobacterium tuberculosis Arch Intern Med 155 1995 854 859
42. S.E. Valway, S.B. Richards, J. Kovacovich, R.B. Greifinger, J.T. Crawford, and S.W. Dooley OuTBreak of multi-drug-resistant tuberculosis in a New York state prison, 1991 Am J Epidemiol 140 1994 113 122
43. T.R. Frieden, L.F. Sherman, K.L. Maw, P.I. Fujiwara, J.T. Crawford, B. Nivin, V. Sharp, D. Hewlett Jr., K. Brudney, D. Alland, and B.N. Kreisworth A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes JAMA 276 1996 1229 1235